Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Adma Biologics (ADMA)

Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Adma Biologics: Q1 Earnings Snapshot

Adma Biologics: Q1 Earnings Snapshot

ADMA : 10.63 (-1.39%)
Chart of the Day: ADMA Biologics - Hitting New Highs

The Chart of the Day belongs to the biomedical company ADMA Biologics (ADMA) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

ADMA : 10.63 (-1.39%)
Adma Biologics: Q4 Earnings Snapshot

Adma Biologics: Q4 Earnings Snapshot

ADMA : 10.63 (-1.39%)
Why Adma Biologics Stock Crushed the Market on Friday

The network of FDA-approved collection facilities continues to grow.

ADMA : 10.63 (-1.39%)
Why Adma Biologics Was Trouncing the Market Today

The company beat analyst estimates for both revenue and profitability, and raised revenue guidance.

ADMA : 10.63 (-1.39%)
Adma Biologics: Q3 Earnings Snapshot

Adma Biologics: Q3 Earnings Snapshot

ADMA : 10.63 (-1.39%)
Why Shares of ADMA Biologics Are Climbing Thursday

The company, which focuses on infectious diseases, reported its second-quarter earnings on Wednesday after the markets closed.

ADMA : 10.63 (-1.39%)
Adma Biologics: Q2 Earnings Snapshot

Adma Biologics: Q2 Earnings Snapshot

ADMA : 10.63 (-1.39%)
Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates

Adma Biologics (ADMA) delivered earnings and revenue surprises of 40% and 10.84%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ADMA : 10.63 (-1.39%)
SABS : 3.15 (-2.48%)
Adma Biologics: Q1 Earnings Snapshot

Adma Biologics: Q1 Earnings Snapshot

ADMA : 10.63 (-1.39%)

Barchart Exclusives

Up 27% YTD, How Much Higher Can This Small-Cap Clean Energy Stock Rise?
SolarBank is a small-cap clean energy company that has outpaced the broader markets in 2024. Is SUUN stock a good buy right now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar